{"id":633422,"date":"2025-09-04T11:32:59","date_gmt":"2025-09-04T15:32:59","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=633422"},"modified":"2025-09-04T11:32:59","modified_gmt":"2025-09-04T15:32:59","slug":"fda-approves-first-generic-glp-1-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/","title":{"rendered":"FDA approves generic Saxenda"},"content":{"rendered":"

Good news for people looking for more affordable options to help them lose weight and keep it off! The U.S. Food and Drug Administration (FDA) approved a generic version of Saxenda<\/a>, a commonly prescribed glucagon-like peptide-1 receptor agonist (<\/span>GLP-1<\/span><\/a>).<\/span><\/p>\n

\u201cWith this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S. the first ever generic GLP-1 product specifically indicated for weight loss,\u201d Ernie Richardsen, Senior Vice President and Head of U.S. Commercial Generics at Teva Pharmaceuticals, Inc., said in a statement.<\/span><\/p>\n

What is Saxenda generic?<\/span><\/h2>\n

Liraglutide<\/a> is a medication that contains the same active ingredient and provides the same benefits as brand-name <\/span>Saxenda<\/span>. It’s approved to treat adults and pediatric patients 12 years and older with obesity who weigh more than 60 kg (132 pounds). It can also be used to treat overweight adults who have at least one weight-related medical condition, such as high cholesterol or high blood pressure.<\/span><\/p>\n

Like other well-known injectable weight-loss drugs, such as Wegovy (semaglutide) and Zepbound (tirzepatide), liraglutide helps regulate cravings and decrease appetite. It also slows down the rate at which the stomach empties to help you feel fuller for longer.\u00a0<\/span><\/p>\n

How does Saxenda generic compare to the brand name?<\/span><\/h3>\n

To gain <\/span>FDA approval<\/span><\/a>, a generic medication must be proven to work the same and provide the same benefits as the brand-name medication. Meaning, you should have the same treatment experience taking generic liraglutide as you would with brand-name Saxenda.\u00a0<\/span><\/p>\n

Saxenda is manufactured by Novo Nordisk. Teva Pharmaceuticals gained approval for generic Saxenda. Both medications are available in the same dose, form, and route of administration.<\/span><\/p>\n

As with Saxenda, people taking liraglutide should also eat a reduced-calorie diet and get regular exercise.\u00a0<\/span><\/p>\n

Why this approval matters<\/span><\/h2>\n

Saxenda was the first <\/span>GLP-1 drug approved<\/span><\/a> to help with weight loss in the U.S., originally approved in December 2014. Since then, the popularity of similar weight-loss medications has surged, though supply and price are often barriers to treatment.<\/span><\/p>\n

For example, a monthly supply of <\/span>Zepbound<\/span><\/a> or <\/span>Wegovy<\/span><\/a> can cost anywhere from $499 to $1,500. The average monthly cost for brand-name <\/span>Saxenda<\/span><\/a> is around $1,800. Typically, generic options cost less than their brand-name counterparts, and prices often continue to decrease as more generic manufacturers enter the market.<\/span><\/p>\n

How much will generic Saxenda cost?<\/span><\/h2>\n

Teva has not announced pricing for generic Saxenda.<\/span><\/p>\n

However, Teva Pharmaceuticals previously received approval for a copycat of <\/span>Victoza<\/span><\/a>, a Type 2 diabetes medication containing liraglutide. The average monthly retail price for that form of liraglutide is around $340, and even less when using a SingleCare <\/span>discount coupon<\/span><\/a>.<\/span><\/p>\n

When will generic Saxenda be available?<\/span><\/h2>\n

Teva Pharmaceuticals announced the approval and U.S. launch of generic Saxenda on August 28, 2025. Because availability may vary by location, check with your local pharmacy to see if it is in stock or if they can order it.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Good news for people looking for more affordable options to help them lose weight and keep it off! The U.S. Food and Drug Administration (FDA) approved a generic version of Saxenda, a commonly prescribed glucagon-like peptide-1 receptor agonist (GLP-1). \u201cWith this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients […]<\/p>\n","protected":false},"author":135,"featured_media":633423,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4114],"tags":[4141,21067],"coauthors":[9482],"class_list":["post-633422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-fda-approvals","tag-glp-1-drugs","wpautop"],"acf":[],"yoast_head":"\nFDA approves first generic GLP-1 for weight loss<\/title>\n<meta name=\"description\" content=\"The FDA has approved generic liraglutide, a bioequivalent of Saxenda, for weight loss. Liraglutide is also approved for Type 2 diabetes as generic Victoza.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves generic Saxenda\" \/>\n<meta property=\"og:description\" content=\"It\u2019s the first generic GLP-1 specifically for weight loss\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/\" \/>\n<meta property=\"og:site_name\" content=\"The Checkup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/singlecare\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T15:32:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jennifer Larson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA approves generic Saxenda\" \/>\n<meta name=\"twitter:description\" content=\"It\u2019s the first generic GLP-1 specifically for weight loss\" \/>\n<meta name=\"twitter:creator\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:site\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jennifer Larson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/\"},\"author\":{\"name\":\"Heidi Borst\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/fda93df2f5d09af0d250b59dfb4b46f2\"},\"headline\":\"FDA approves generic Saxenda\",\"datePublished\":\"2025-09-04T15:32:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/\"},\"wordCount\":475,\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/FDA_approval_Saxenda.png\",\"keywords\":[\"FDA approvals\",\"GLP-1 drugs\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/\",\"name\":\"FDA approves first generic GLP-1 for weight loss\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/FDA_approval_Saxenda.png\",\"datePublished\":\"2025-09-04T15:32:59+00:00\",\"description\":\"The FDA has approved generic liraglutide, a bioequivalent of Saxenda, for weight loss. Liraglutide is also approved for Type 2 diabetes as generic Victoza.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/FDA_approval_Saxenda.png\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/FDA_approval_Saxenda.png\",\"width\":1920,\"height\":1080,\"caption\":\"FDA stamp - Saxenda generic FDA approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-first-generic-glp-1-for-weight-loss\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves generic Saxenda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"name\":\"The Checkup, a health blog by SingleCare\",\"description\":\"Read the latest in prescription, wellness, and healthcare news\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\",\"name\":\"SingleCare\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"width\":1200,\"height\":630,\"caption\":\"SingleCare\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/singlecare\",\"https:\\\/\\\/x.com\\\/SingleCare\",\"https:\\\/\\\/www.instagram.com\\\/singlecare\\\/?hl=en\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/singlecare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCd9kiPIjCQw95-2BHCYePKA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/fda93df2f5d09af0d250b59dfb4b46f2\",\"name\":\"Heidi Borst\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g5fb1f533c8ee6da65648bfe7ca214e71\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g\",\"caption\":\"Heidi Borst\"},\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/author\\\/hborstrxsense-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA approves first generic GLP-1 for weight loss","description":"The FDA has approved generic liraglutide, a bioequivalent of Saxenda, for weight loss. Liraglutide is also approved for Type 2 diabetes as generic Victoza.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves generic Saxenda","og_description":"It\u2019s the first generic GLP-1 specifically for weight loss","og_url":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/","og_site_name":"The Checkup","article_publisher":"https:\/\/www.facebook.com\/singlecare","article_published_time":"2025-09-04T15:32:59+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png","type":"image\/png"}],"author":"Jennifer Larson","twitter_card":"summary_large_image","twitter_title":"FDA approves generic Saxenda","twitter_description":"It\u2019s the first generic GLP-1 specifically for weight loss","twitter_creator":"@SingleCare","twitter_site":"@SingleCare","twitter_misc":{"Written by":"Jennifer Larson","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#article","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/"},"author":{"name":"Heidi Borst","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/fda93df2f5d09af0d250b59dfb4b46f2"},"headline":"FDA approves generic Saxenda","datePublished":"2025-09-04T15:32:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/"},"wordCount":475,"publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png","keywords":["FDA approvals","GLP-1 drugs"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/","url":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/","name":"FDA approves first generic GLP-1 for weight loss","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#primaryimage"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png","datePublished":"2025-09-04T15:32:59+00:00","description":"The FDA has approved generic liraglutide, a bioequivalent of Saxenda, for weight loss. Liraglutide is also approved for Type 2 diabetes as generic Victoza.","breadcrumb":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#primaryimage","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/09\/FDA_approval_Saxenda.png","width":1920,"height":1080,"caption":"FDA stamp - Saxenda generic FDA approval"},{"@type":"BreadcrumbList","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-first-generic-glp-1-for-weight-loss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.singlecare.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA approves generic Saxenda"}]},{"@type":"WebSite","@id":"https:\/\/www.singlecare.com\/blog\/#website","url":"https:\/\/www.singlecare.com\/blog\/","name":"The Checkup, a health blog by SingleCare","description":"Read the latest in prescription, wellness, and healthcare news","publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.singlecare.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.singlecare.com\/blog\/#organization","name":"SingleCare","url":"https:\/\/www.singlecare.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","width":1200,"height":630,"caption":"SingleCare"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/singlecare","https:\/\/x.com\/SingleCare","https:\/\/www.instagram.com\/singlecare\/?hl=en","https:\/\/www.linkedin.com\/company\/singlecare\/","https:\/\/www.youtube.com\/channel\/UCd9kiPIjCQw95-2BHCYePKA"]},{"@type":"Person","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/fda93df2f5d09af0d250b59dfb4b46f2","name":"Heidi Borst","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g5fb1f533c8ee6da65648bfe7ca214e71","url":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g","caption":"Heidi Borst"},"url":"https:\/\/www.singlecare.com\/blog\/author\/hborstrxsense-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/633422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/users\/135"}],"replies":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/comments?post=633422"}],"version-history":[{"count":0,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/633422\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media\/633423"}],"wp:attachment":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media?parent=633422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/categories?post=633422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/tags?post=633422"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/coauthors?post=633422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}